Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Influence of antipsychotics on metabolic syndrome risk in patients with schizophrenia

Bibliographic Data

ID15525823
AuthorsAleksandra Koricanac (University of Kragujevac), Aleksandra Tomić-Lučić (0000-0002-1895-7519, University of Kragujevac, corresponding author), Aleksandra Tomic Lucic, Mirjana Veselinović (0000-0001-7586-7440, University of Kragujevac), Danijela Bazic Sretenovic (0000-0002-4622-7636, University of Kragujevac), Gorica Bucic (Clinical Centre of Kragujevac), Anja Azanjac (University of Kragujevac), Olivera Radmanović (Clinical Centre of Kragujevac), Mirjana Matovic (University of Kragujevac), Marijana Stanojevic (Clinical Centre of Kragujevac), Aleksandra Jurišić-Škevin (0000-0002-8035-6167, University of Kragujevac), Aleksandra Jurisic Skevin, Bojana Simović Marković (0000-0001-8408-4624, University of Kragujevac), Jelena Pantić (0000-0003-0602-4815, University of Kragujevac), Nebojša Arsenijević (0000-0002-2107-3490, University of Kragujevac), Gordana Radosavljević (0000-0001-6016-0725, University of Kragujevac), Gordana D Radosavljevic, Maja Nikolic (0000-0003-3993-0785, University of Kragujevac), Nenad Zornić (0000-0002-8727-4279, University of Kragujevac), Jelena Nešić (0000-0003-4262-1166, University of Kragujevac), Nemanja Murić (0000-0003-1613-4778, University of Kragujevac), Branimir Radmanović (0000-0002-1690-4691, Clinical Centre of Kragujevac)
Year2022
Volume13
Pages925757-925757
Publication date2022-07-25
Peer ReviewedYes
Open AccessYes
TypeARTICLE
VenueFrontiers in Psychiatry (JOURNAL)
Journal identifiersISSN: 1664-0640 • E-ISSN: 1664-0640
PublisherFrontiers Media (PUBLISHER • CH)
DOI10.3389/fpsyt.2022.925757
PMID35958655
OpenAlexW4287091852
LanguageEN
References cited57

Patients on risperidone and clozapine therapy may be at greater risk of developing metabolic syndrome than patients treated with aripiprazole. Statistically significant difference in concentration of TNF-α and TGF-β was in the group of patients treated with risperidone compared to healthy control group

Antipsychotic · Aripiprazole · Body mass index · Cholesterol · Clozapine · Insulin · Insulin resistance · Leptin · Lipid Profile · Metabolic syndrome · Obesity · Olanzapine · Positive and Negative Syndrome Scale · Psychiatry · Psychosis · Risperidone · Schizophrenia (object-oriented programming · Waist · Diabetes and associated disorders · Medicine · Schizophrenia research and treatment · Tryptophan and brain disorders · Endocrinology · Internal Medicine

  • The metabolic syndrome

    Open Access•Robert H Eckel, Scott M Grundy et al.•The Lancet•2005

  • Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia

    Stefan Leucht, Andrea Cipriani et al.•The Lancet•2013

  • Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder

    Open Access•Davy Vancampfort, Brendon Stubbs et al.•World Psychiatry•2015

  • IL-33/ST2 Pathway and Galectin-3 as a New Analytes in Pathogenesis and Cardiometabolic Risk Evaluation in Psychosis

    Open Access•Milica Borovčanin, Milica M Borovcanin et al.•Frontiers in Psychiatry•2018

Citation velocityhistorical
Highly citedNo

Tools

Open DOIOpen Access
Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae